RenalSense

RenalSense
RenalSense develops Clarity RMS, a real-time urine flow monitoring system for early detection of acute kidney injury in critical care.
About
What does RenalSense do?
RenalSense is a medical device company focused on real-time renal diagnostics. Their flagship product, Clarity RMS, provides continuous, automated urine output monitoring in critical care settings, enabling early detection of acute kidney injury (AKI) and guiding fluid management decisions for improved patient outcomes.
What is RenalSense's revenue?
StartupHub estimates RenalSense's annual revenue at $1.3M (range $687K to $1.8M, 66% confidence), based on comparable companies in the sector.
What is RenalSense's valuation?
StartupHub estimates RenalSense's effective valuation at $138.7M (range $85.0M to $204.0M, 10% confidence), based on comparable companies in the sector.
How much funding has RenalSense raised?
RenalSense has raised a total of $34M in funding. The most recent round on record is Series A.
Where is RenalSense headquartered?
RenalSense is headquartered in Netanya, Israel.
When was RenalSense founded?
RenalSense was founded in 2009.
What industry does RenalSense operate in?
RenalSense operates in Healthcare, ICU Management, Urine, Patient Care, Monitoring, MedTech.
How many employees does RenalSense have?
RenalSense has approximately 7 people on record.
What is RenalSense's current status?
RenalSense's current operating status is: Inactive.
“CHFS partnership announced this morning. They also voted for NO REVERSE SPLIT after not completing there canceled meeting June 19th. With the webinar tomorrow hope to expect a continued run up until tomorrow morning.”
View on Reddit“RenalSense Announces Distribution Agreement With Fresenius Medical Care.   submitted by   /u/prnewswireadmin   to   r/prnewswire [link]   [comments]”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.